merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>Gives critics momentum and may make securing the needed coalition harder</answer>
<question_number>2</question_number>
<answer>Lack of transparency and perceived vaccine waste fueled distrust that aided far‑right gains</answer>
<question_number>3</question_number>
<answer>Angered Greens, threatening their support and narrowing her coalition</answer>
<question_number>4</question_number>
<answer>Transparency concerns linked to procurement strategy contributed to voter distrust amid far‑right surge</answer>
<question_number>5</question_number>
<answer>Ruling highlights secrecy that has fed distrust, coinciding with far‑right gains</answer>
<question_number>6</question_number>
<answer>Arrived just before the secret vote, giving critics momentum and possibly swaying MPs</answer>
<question_number>7</question_number>
<answer>Shift from a slow, conservative start to securing a large Pfizer‑BioNTech deal that helped the EU catch up and surpass others</answer>
<question_number>8</question_number>
<answer>Claims to provide full information while having redacted contracts and withheld details</answer>
<question_number>9</question_number>
<answer>Both involve demands for disclosure of von der Leyen’s communications with Pfizer; NYT welcomed the ruling</answer>
<question_number>10</question_number>
<answer>May increase public distrust of the EU’s pandemic response by exposing secrecy, reinforcing concerns that have aided far‑right sentiment</answer>